.gif) |
|
Back To Happy And Healthy Life . .
. | |
|
|
| |
|
The Best Place To Find The Cheapest Sonata
|
Drug name:
Sonata
Indications
and usage:
SONATA is
indicated for the short-term treatment of
insomnia. This medicine has been shown to decrease the
time to sleep onset for up to 30 days in
controlled clinical studies
Hypnotics like
SONATA should generally be limited to 7 to 10 days
of use, and reevaluation of the patient is
recommended if they are to be taken for more than
2 to 3 weeks. |
 |
Overview:
SONATA is indicated for short-term
insomnia treatment. This medication should generally be limited
to 7-10 days use, and reevaluation of patients is
recommended if SONATA is taken more than 2-3 weeks.
Until you know how you will react to SONATA, you should
not engage in activities requiring mental alertness or
motor coordination (e.g. driving or operating machinery)
after taking SONATA or any sleep agent. In clinical
trials, the most common side effects were
headache, dizziness, and somnolence. As with any
sedative/hypnotic, abrupt treatment discontinuation can
produce signs and symptoms of withdrawal and rebound
insomnia.
Dosage and administration:
The dose should be
individualized. The recommended dose for most
adults is 10 mg. For certain low weight individuals, 5
mg may be a sufficient dose.
SONATA should
be taken immediately before bedtime or after the patient
has gone to bed and has experienced difficulty falling
asleep. Taking the medicine with or immediately after a heavy,
high-fat meal results in slower absorption and would be
expected to reduce the effect on sleep
latency.
How to use:
Take SONATA by mouth, immediately before
bedtime or after you have gone to bed and have
difficulty sleeping, as directed by your doctor. This medication helps you fall asleep. To
minimize side effects while you are awake (e.g.,
dizziness or memory trouble), take SONATA when you are
in bed and are able to get at least four hours of sleep
before you need to be active again. Do not use this medicine
for longer than ten days without your doctor's approval.
If your sleep problems continue, consult with your
doctor. Do not
increase your dose.
if SONATA is used for a longer period of time, do not
stop using this medication without your doctor's
approval.
Special populations:
Elderly patients and debilitated patients
appear to be more sensitive to the effects of SONATA and
respond to 5 mg of SONATA. The recommended dose for these patients is therefore 5 mg. Doses over
10 mg are not recommended.
Liver impairment:
Patients with mild to moderate liver impairment should
be treated with SONATA 5 mg because clearance is reduced
in this population. This medication is not recommended for use in
patients with severe liver impairment.
Kidney
impairmet: No Sonata dose adjustment is necessary in
patients with mild to moderate kidney impairment. Sonata
has not been adequately studied in patients with severe
kidney impairment.
An initial dose of 5 mg
should be given to patients concomitantly taking
cimetidine because SONATA clearance is reduced in this
population.
Side effects:
SONATA may cause headache, drowsiness,
nausea or stomach upset may occur. If any of these
effects persist or worsen, notify your doctor
promptly. Tell your doctor immediately if you have any
of these serious side effects :
dizziness, weakness, loss of coordination, muscle joint
pain. Tell your doctor immediately if you have any of
these unlikely but serious side effects: mental/mood
changes, persistent trouble sleeping, memory problems,
loss of appetite, tingling of the hands or feet, rash,
itching, tremors, eye/ear problems. Tell your doctor
immediately if you have any of these very unlikely but
serious side effects: fast/slow/irregular pulse, chest
pain, trouble breathing, blood in the stool, unusual
thirst, change in amount of urine. If you notice other
effects not listed above, contact your
doctor or pharmacist.
Warnings:
Because sleep disturbances may be the
presenting manifestation of a physical and/or
psychiatric disorder, symptomatic treatment of insomnia
with SONATA should be initiated only after a careful
evaluation of the patient. The failure of insomnia to
remit after 7 to 10 days of treatment with SONATA may
indicate the presence of a primary psychiatric and/or
medical illness that should be evaluated. Worsening of
insomnia or the emergence of new thinking or behavior
abnormalities may be the consequence of an unrecognized
psychiatric or physical disorder. Such findings have
emerged during the course of treatment with
sedative/hypnotic drugs, including Sonata. Because some
of the important adverse effects of Sonata appear to be
dose-related, it is important to use the lowest possible
effective dose, especially in the elderly.
A
variety of abnormal thinking and behavior changes have
been reported to occur in association with the use of
sedative/hypnotics like SONATA. Some of these changes
may be characterized by decreased inhibition (e.g.,
aggressiveness and extroversion that seem out of
character), similar to effects produced by alcohol and
other CNS depressants. Other reported behavioral changes
with SONATA have included bizarre behavior, agitation,
hallucinations, and depersonalization. Amnesia and other
neuropsychiatric symptoms may occur unpredictably. In
primarily depressed patients, worsening of depression,
including suicidal thinking, has been reported in
association with the use of sedative/hypnotics.
It can rarely be determined with certainty
whether a particular instance of the abnormal behaviors
listed above is SONATA induced, spontaneous in origin,
or a result of an underlying psychiatric or physical
disorder. Nonetheless, the emergence of any new
behavioral sign or symptom of concern while taking
the medicine requires careful and immediate evaluation.
Following rapid dose decrease or abrupt
discontinuation of the use of SONATA, there have been
reports of signs and symptoms similar to those
associated with withdrawal.
SONATA, like other hypnotics, has
CNS-depressant effects. Because of the rapid onset of
action, SONATA should only be ingested immediately prior
to going to bed or after the patient has gone to bed and
has experienced difficulty falling asleep. Patients
receiving SONATA should be cautioned against engaging in
hazardous occupations requiring complete mental
alertness or motor coordination (e.g., operating
machinery or driving a motor vehicle) after ingesting
the drug, including potential impairment of the
performance of such activities that may occur the day
following ingestion of SONATA. It may produce additive CNS-depressant effects
when co administered with other psychotropic
medications, anticonvulsants, antihistamines, narcotic
analgesics, anesthetics, ethanol, and other drugs that
themselves produce CNS depression. SONATA should not be
taken with alcohol. The dosage adjustment may be
necessary when it is administered with other
CNS-depressant agents because of the potentially
additive effects.
|
| |
Propecia